COVID-19 Business Intelligence and Analysis for Clinical Laboratories, Pathology Groups and Hospital Administration

COVID-19 Briefings

Reliable COVID-19 Business Intelligence and analysis for clinical laboratories, pathology groups and Laboratory Diagnostics.

FDA Changes Storage Requirements for Pfizer COVID-19 Vaccine, Facilitating Faster and More Widespread Use

FDA maze of regulations
Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on pinterest
Pinterest
Share on whatsapp
WhatsApp
Share on email
Email
Share on facebook
Share on twitter
Share on linkedin
Share on google
Share on whatsapp
Share on email

New storage requirement for Pfizer vaccine makes it easier for clinical laboratory personnel to access vaccine

The US Food and Drug Administration (FDA) announced changes to stringent storage requirements previously in place for the Pfizer COVID-19 vaccine. Previous guidelines required ultra-cold storage of the vaccine (temperature from -80°C to -60°C). These guidelines made transporting and storing this vaccine logistically difficult and slowed its initial role out.

New FDA guidelines now allow for storage at standard freezer temperatures for up to two weeks. While the colder temperature requirements did help maintain the vaccine’s stability for up to six months, the loosened requirements will make shipping and storing easy enough that the two-week timeframe should not significantly affect vaccine delivery and administration.

“Alternative temperature for transportation and storage will help ease the burden of procuring ultra-low cold storage equipment for vaccination sites and should help to get the vaccine to more sites,” said Peter Marks, MD, PhD, Director of the FDA’s Center for Biologics Evaluation and Research.

As the Pfizer vaccine becomes more widely available and the US begins to reach herd immunity, COVID-19 testing volumes could be impacted. However, clinical laboratory staff will have improved accessibility to vaccines as well, and that could potentially reduce clinical laboratory staffing shortages.

Related Resources:

COVID-19 TESTING DATA

Helping Your Lab Stay Afloat During Challenging Times

Dear Colleague,

Robert L. MichelIn these challenging times for our colleagues in clinical laboratories, pathology practices and hospital administration, The Dark Intelligence Group (TDIG) — through generous grants from our partners — is bringing you the COVID-19 STAT Intelligence Briefings.

We’ve added analysts, writers and skilled editors to the COVID-19 STAT team to uncover, analyze, and immediately report to you what’s happening with the SARS-CoV-2 pandemic, packaged with the insights you need to deliver quality testing for patient care and keep your lab’s financial ship afloat. As part of our mission, we are also bringing you real-time data from our partners around testing that you will not find anywhere else.

Please let me know how we can better improve this service to fit your needs. If you would like to offer a grant to keep our mission going with this site, please contact me at rmichel@darkreport.com.

Sincerely,

Robert L. Michel
President, Founder
The Dark Intelligence Group